128 related articles for article (PubMed ID: 36639280)
1. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
3. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
[TBL] [Abstract][Full Text] [Related]
4. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
[TBL] [Abstract][Full Text] [Related]
5. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
6. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
Liu Y; Huang C; Liu H; Chen Y; Li S
World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
[TBL] [Abstract][Full Text] [Related]
8. A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer.
Mu JW; Gao SG; Xue Q; Zhao J; Li N; Yang K; Su K; Yuan ZY; He J
Chin Med J (Engl); 2015 Oct; 128(20):2731-5. PubMed ID: 26481738
[TBL] [Abstract][Full Text] [Related]
9. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
10. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
11. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies.
Fan J; Wang L; Jiang GN; Gao W
Ann Surg Oncol; 2012 Feb; 19(2):661-8. PubMed ID: 21769464
[TBL] [Abstract][Full Text] [Related]
12. Node-Positive Segmentectomy for Non-Small-Cell Lung Cancer: Risk Factors and Outcomes.
Lutfi W; Schuchert MJ; Dhupar R; Ekeke C; Sarkaria IS; Christie NA; Luketich JD; Okusanya OT
Clin Lung Cancer; 2019 Jul; 20(4):e463-e469. PubMed ID: 31031205
[TBL] [Abstract][Full Text] [Related]
13. Surgery for stage IIB-IIIB small cell lung cancer.
Huang Z; Liu Y; Wang S; Ai K; Zhang P
World J Surg Oncol; 2023 Oct; 21(1):333. PubMed ID: 37872542
[TBL] [Abstract][Full Text] [Related]
14. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Relevance of Negative Lymph Node Count in Resected Stage I-IIIa Small-cell Lung Cancer.
Yang H; Li D; Liu T
Am J Clin Oncol; 2023 Jul; 46(7):306-313. PubMed ID: 37102621
[TBL] [Abstract][Full Text] [Related]
16. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.
Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J
Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654
[TBL] [Abstract][Full Text] [Related]
17. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
Wang L; Ge L; You S; Liu Y; Ren Y
J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
[TBL] [Abstract][Full Text] [Related]
18. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
19. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.
Razi SS; John MM; Sainathan S; Stavropoulos C
J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227
[TBL] [Abstract][Full Text] [Related]
20. Lobectomy Versus Sublobectomy in Metachronous Second Primary Lung Cancer: A Propensity Score Study.
Yang X; Zhan C; Li M; Huang Y; Zhao M; Yang X; Lin Z; Shi Y; Jiang W; Wang Q
Ann Thorac Surg; 2018 Sep; 106(3):880-887. PubMed ID: 29852145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
